Founder Lodge | Exchange with founders who raised capital, hired employees & got cashflow.

Certified by Founder Lodge

Oxford Science Enterprises

Venture Capital and Private Equity Principals,

United Kingdom - Oxford, England

INVESTOR

1 Disclosed Funding Rounds $85,000,000
27 Participating Investments

Organizations in Oxford, England in Venture Capital and Private Equity Principals

Investors in Oxford, England in Venture Capital and Private Equity Principals

Operating Status
Active
Last Funding Type
Seed
Company Type
For Profit
Website
https://oxfordscienceenterprises.com/
Contact
Hunter Lookup
Social Links

Oxford Science Enterprises (OSE) is an independent, billion-pound investment company, created in 2015 to found, fund and build transformational businesses via our unique partnership with the

Company	Date	Round	Raised
BibliU	June, 09 ,2022	Series B	$15,000,000
Osler Diagnostics	November, 07 ,2022	Series C	$85,000,000
Oxford Ionics	January, 12 ,2023	Series A	$36,500,000
Salience Labs	May, 12 ,2022	Seed	$11,500,000
BibliU	June, 09 ,2022	Series B	$15,000,000
Mixergy Ltd	March, 28 ,2023	Unknown	$11,326,000
Salience Labs	May, 12 ,2022	Seed	$11,500,000
PQShield	January, 26 ,2022	Series A	$20,000,000
Mixergy Ltd	March, 28 ,2023	Unknown	$11,326,000
Caristo Diagnostics	April, 18 ,2023	Series A	$16,300,000
PQShield	January, 26 ,2022	Series A	$20,000,000
Prolific	July, 14 ,2023	Unknown	$32,764,500
Caristo Diagnostics	April, 18 ,2023	Series A	$16,300,000
AlveoGene	September, 15 ,2023	Seed
Prolific	July, 14 ,2023	Unknown	$32,764,500
Navenio	September, 21 ,2023	Unknown	$6,300,000
AlveoGene	September, 15 ,2023	Seed
Sitryx	September, 28 ,2023	Unknown	$39,500,000
Navenio	September, 21 ,2023	Unknown	$6,300,000
Oxford Quantum Circuits	November, 28 ,2023	Unknown	$100,000,000
Sitryx	September, 28 ,2023	Unknown	$39,500,000
Grey Wolf Therapeutics	May, 23 ,2024	Series B	$50,000,000
Oxford Quantum Circuits	November, 28 ,2023	Unknown	$100,000,000
Beacon Therapeutics	July, 10 ,2024	Series B	$170,000,000
Grey Wolf Therapeutics	May, 23 ,2024	Series B	$50,000,000
Beacon Therapeutics	July, 10 ,2024	Series B	$170,000,000
Fractile	July, 26 ,2024	Seed	$15,000,000